{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:54:13Z","timestamp":1793091253076,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s11427-022-2264-1","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T07:48:18Z","timestamp":1676620098000},"page":"743-753","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for Escherichia coli-based vaccine design"],"prefix":"10.1007","volume":"66","author":[{"given":"Tingting","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siting","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"key":"2264_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2165\/00063030-199810020-00005","volume":"10","author":"JC Adkins","year":"1998","unstructured":"Adkins, J.C., and Wagstaff, A.J. (1998). Recombinant hepatitis B vaccine: a review of its immunogenicity and protective efficacy against hepatitis B. Biodrugs 10, 137\u2013158.","journal-title":"Biodrugs"},{"key":"2264_CR2","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1093\/infdis\/166.Supplement_1.S35","volume":"166","author":"AM Arvin","year":"1992","unstructured":"Arvin, A.M. (1992). Cell-mediated immunity to varicella-zoster virus. J Infect Dis 166, S35\u2013S41.","journal-title":"J Infect Dis"},{"key":"2264_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/vaccines9040310","volume":"9","author":"H Cao","year":"2021","unstructured":"Cao, H., Wang, Y., Luan, N., and Liu, C. (2021). Immunogenicity of varicella-zoster virus glycoprotein E formulated with lipid nanoparticles and nucleic immunostimulators in mice. Vaccines 9, 310.","journal-title":"Vaccines"},{"key":"2264_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jviromet.2014.01.014","volume":"200","author":"L Chen","year":"2014","unstructured":"Chen, L., Liu, J., Wang, W., Ye, J., Wen, L., Zhao, Q., Zhu, H., Cheng, T., and Xia, N. (2014). Development of a varicella-zoster virus neutralization assay using a glycoprotein K antibody enzyme-linked immunosorbent spot assay. J Virol Methods 200, 10\u201314.","journal-title":"J Virol Methods"},{"key":"2264_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJMcp1302674","volume":"369","author":"JI Cohen","year":"2013","unstructured":"Cohen, J.I. (2013). Clinical practice: herpes zoster. N Engl J Med 369, 255\u2013263.","journal-title":"N Engl J Med"},{"key":"2264_CR6","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1016\/j.vaccine.2012.01.088","volume":"30","author":"N Dendouga","year":"2012","unstructured":"Dendouga, N., Fochesato, M., Lockman, L., Mossman, S., and Giannini, S. L. (2012). Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice. Vaccine 30, 3126\u20133135.","journal-title":"Vaccine"},{"key":"2264_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1006\/viro.1995.0064","volume":"214","author":"WJ Fowler","year":"1995","unstructured":"Fowler, W.J., Garcia-valcarcel, M., Hill-perkins, M.S., Murphy, G., Harper, D.R., Jeffries, D.J., Burns, N.R., Adams, S.E., Kingsman, A.J., and Layton, G.T. (1995). Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus. Virology 214, 531\u2013540.","journal-title":"Virology"},{"key":"2264_CR8","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.1086\/522125","volume":"197","author":"SA Galea","year":"2008","unstructured":"Galea, S.A., Sweet, A., Beninger, P., Steinberg, S.P., LaRussa, P.S., Gershon, A.A., and Sharrar, R.G. (2008). The safety profile of varicella vaccine: a 10-year review. J Infect Dis 197, S165\u2013S169.","journal-title":"J Infect Dis"},{"key":"2264_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0168-1702(01)00281-7","volume":"79","author":"WL Gray","year":"2001","unstructured":"Gray, W.L., Mullis, L.B., and Soike, K.F. (2001). Expression of the Simian varicella virus glycoprotein E. Virus Res 79, 27\u201337.","journal-title":"Virus Res"},{"key":"2264_CR10","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","volume":"368","author":"U Heininger","year":"2006","unstructured":"Heininger, U., and Seward, J.F. (2006). Varicella. Lancet 368, 1365\u20131376.","journal-title":"Lancet"},{"key":"2264_CR11","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00253-011-3758-5","volume":"93","author":"JY Kim","year":"2012","unstructured":"Kim, J.Y., Kim, Y.G., and Lee, G.M. (2012). CHO cells in biotechnology for production of recombinant proteins: current state and further potential. Appl Microbiol Biotechnol 93, 917\u2013930.","journal-title":"Appl Microbiol Biotechnol"},{"key":"2264_CR12","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal, H., Cunningham, A.L., Godeaux, O., Chlibek, R., Diez-Domingo, J., Hwang, S.J., Levin, M.J., McElhaney, J.E., Poder, A., Puig-Barber\u00e0, J., et al. (2015). Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 372, 2087\u20132096.","journal-title":"N Engl J Med"},{"key":"2264_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/iid3.297","volume":"8","author":"SJ Lee","year":"2020","unstructured":"Lee, S.J., Park, H.J., Ko, H.L., Lee, J.E., Lee, H.J., Kim, H., and Nam, J.H. (2020). Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant. Immun Inflamm Dis 8, 216\u2013227.","journal-title":"Immun Inflamm Dis"},{"key":"2264_CR14","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1007\/s00253-015-6602-5","volume":"99","author":"J Liu","year":"2015","unstructured":"Liu, J., Zhu, R., Ye, X., Yang, L., Wang, Y., Huang, Y., Wu, J., Wang, W., Ye, J., Li, Y., et al. (2015). A monoclonal antibody-based VZV glycoprotein E quantitative assay and its application on antigen quantitation in VZV vaccine. Appl Microbiol Biotechnol 99, 4845\u20134853.","journal-title":"Appl Microbiol Biotechnol"},{"key":"2264_CR15","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3390\/pharmaceutics14050973","volume":"14","author":"N Luan","year":"2022","unstructured":"Luan, N., Cao, H., Wang, Y., Lin, K., and Liu, C. (2022a). Ionizable lipid nanoparticles enhanced the synergistic adjuvant effect of CpG ODNs and QS21 in a varicella zoster virus glycoprotein E subunit vaccine. Pharmaceutics 14, 973.","journal-title":"Pharmaceutics"},{"key":"2264_CR16","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.virs.2022.06.002","volume":"37","author":"N Luan","year":"2022","unstructured":"Luan, N., Cao, H., Wang, Y., Lin, K., and Liu, C. (2022b). LNP-CpG ODN-adjuvanted varicella-zoster virus glycoprotein E induced comparable levels of immunity with Shingrix\u2122 in VZV-primed mice. Virol Sin 37, 731\u2013739.","journal-title":"Virol Sin"},{"key":"2264_CR17","first-page":"97","volume":"2","author":"A Monie","year":"2008","unstructured":"Monie, A., Hung, C.F., Roden, R., and Wu, T.C. (2008). Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer. Biologics 2, 97\u2013105.","journal-title":"Biologics"},{"key":"2264_CR18","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/ijms20040954","volume":"20","author":"R Nord\u00e9n","year":"2019","unstructured":"Nord\u00e9n, R., Nilsson, J., Samuelsson, E., Risinger, C., Sihlbom, C., Blixt, O., Larson, G., Olofsson, S., and Bergstr\u00f6m, T. (2019). Recombinant glycoprotein E of varicella zoster virus contains glycan-peptide motifs that modulate B cell epitopes into discrete immunological signatures. Int J Mol Sci 20, 954.","journal-title":"Int J Mol Sci"},{"key":"2264_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s40588-016-0044-4","volume":"3","author":"SL Oliver","year":"2016","unstructured":"Oliver, S.L., Yang, E., and Arvin, A.M. (2016). Varicella-zoster virus glycoproteins: entry, replication, and pathogenesis. Curr Clin Microbiol Rep 3, 204\u2013215.","journal-title":"Curr Clin Microbiol Rep"},{"key":"2264_CR20","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.drudis.2013.11.008","volume":"19","author":"TW Overton","year":"2014","unstructured":"Overton, T.W. (2014). Recombinant protein production in bacterial hosts. Drug Discov Today 19, 590\u2013601.","journal-title":"Drug Discov Today"},{"key":"2264_CR21","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman, M.N., Levin, M.J., Johnson, G.R., Schmader, K.E., Straus, S.E., Gelb, L.D., Arbeit, R.D., Simberkoff, M.S., Gershon, A.A., Davis, L.E., et al. (2005). A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352, 2271\u20132284.","journal-title":"N Engl J Med"},{"key":"2264_CR22","first-page":"5","volume":"24","author":"RA Shah","year":"2019","unstructured":"Shah, R.A., Limmer, A.L., Nwannunu, C.E., Patel, R.R., Mui, U.N., and Tyring, S.K. (2019). Shingrix for herpes zoster: a review. Skin Therapy Lett 24, 5\u20137.","journal-title":"Skin Therapy Lett"},{"key":"2264_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1263\/jbb.99.303","volume":"99","author":"SM Singh","year":"2005","unstructured":"Singh, S.M., and Panda, A.K. (2005). Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng 99, 303\u2013310.","journal-title":"J Biosci Bioeng"},{"key":"2264_CR24","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s40266-018-0603-x","volume":"35","author":"YY Syed","year":"2018","unstructured":"Syed, Y.Y. (2018). Recombinant zoster vaccine (Shingrix\u00ae): a review in herpes zoster. Drugs Aging 35, 1031\u20131040.","journal-title":"Drugs Aging"},{"key":"2264_CR25","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","volume":"304","author":"M Takahashi","year":"1974","unstructured":"Takahashi, M., Otsuka, T., Okuno, Y., Asano, Y., Yazaki, T., and Isomura, S. (1974). Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 304, 1288\u20131290.","journal-title":"Lancet"},{"key":"2264_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1001\/jama.2010.1983","volume":"305","author":"HF Tseng","year":"2011","unstructured":"Tseng, H.F., Smith, N., Harpaz, R., Bialek, S.R., Sy, L.S., and Jacobsen, S. J. (2011). Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA 305, 160\u2013166.","journal-title":"JAMA"},{"key":"2264_CR27","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0264-410X(94)80030-4","volume":"12","author":"A Vafai","year":"1994","unstructured":"Vafai, A. (1994). Antibody-binding sites on truncated forms of varicella-zoster virus gpI(gE) glycoprotein. Vaccine 12, 1265\u20131269.","journal-title":"Vaccine"},{"key":"2264_CR28","doi-asserted-by":"publisher","first-page":"e01641","DOI":"10.1128\/JVI.01641-20","volume":"94","author":"H Voic","year":"2020","unstructured":"Voic, H., de Vries, R.D., Sidney, J., Rubiro, P., Moore, E., Phillips, E., Mallal, S., Schwan, B., Weiskopf, D., Sette, A., et al. (2020). Identification and characterization of CD4+ T cell epitopes after Shingrix vaccination. J Virol 94, e01641\u201320.","journal-title":"J Virol"},{"key":"2264_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12250-020-00261-y","volume":"36","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Qi, J., Cao, H., and Liu, C. (2021). Immune responses to varicella-zoster virus glycoprotein E formulated with poly(lactic-coglycolic acid) nanoparticles and nucleic acid adjuvants in mice. Virol Sin 36, 122\u2013132.","journal-title":"Virol Sin"},{"key":"2264_CR30","doi-asserted-by":"publisher","first-page":"823","DOI":"10.4161\/hv.20042","volume":"8","author":"T Wu","year":"2012","unstructured":"Wu, T., Li, S.W., Zhang, J., Ng, M.H., Xia, N.S., and Zhao, Q. (2012). Hepatitis E vaccine development: a 14 year odyssey. Hum Vaccin Immunother 8, 823\u2013827.","journal-title":"Hum Vaccin Immunother"},{"key":"2264_CR31","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/j.vaccine.2019.02.048","volume":"37","author":"SR Wui","year":"2019","unstructured":"Wui, S.R., Kim, K.S., Ryu, J.I., Ko, A., Do, H.T.T., Lee, Y.J., Kim, H.J., Lim, S.J., Park, S.A., Cho, Y.J., et al. (2019). Efficient induction of cell-mediated immunity to varicella-zoster virus glycoprotein E colyophilized with a cationic liposome-based adjuvant in mice. Vaccine 37, 2131\u20132141.","journal-title":"Vaccine"},{"key":"2264_CR32","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/pharmaceutics13030390","volume":"13","author":"SR Wui","year":"2021","unstructured":"Wui, S.R., Ko, A., Ryu, J.I., Sim, E., Lim, S.J., Park, S.A., Kim, K.S., Kim, H., Youn, H., and Lee, N.G. (2021). The effect of a TLR4 agonist\/cationic liposome adjuvant on varicella-zoster virus glycoprotein E vaccine efficacy: antigen presentation, uptake, and delivery to lymph nodes. Pharmaceutics 13, 390.","journal-title":"Pharmaceutics"},{"key":"2264_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrmicro3215","volume":"12","author":"L Zerboni","year":"2014","unstructured":"Zerboni, L., Sen, N., Oliver, S.L., and Arvin, A.M. (2014). Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol 12, 197\u2013210.","journal-title":"Nat Rev Microbiol"},{"key":"2264_CR34","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.vaccine.2016.02.007","volume":"34","author":"R Zhu","year":"2016","unstructured":"Zhu, R., Liu, J., Chen, C., Ye, X., Xu, L., Wang, W., Zhao, Q., Zhu, H., Cheng, T., and Xia, N. (2016). A highly conserved epitope-vaccine candidate against varicella-zoster virus induces neutralizing antibodies in mice. Vaccine 34, 1589\u20131596.","journal-title":"Vaccine"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-022-2264-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-022-2264-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-022-2264-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:37:20Z","timestamp":1744159040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-022-2264-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2264"],"URL":"https:\/\/doi.org\/10.1007\/s11427-022-2264-1","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,9]]},"assertion":[{"value":"15 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}